Development And Commercialization Agreement Sample Contracts

Syndax Pharmaceuticals Inc – License, Development and Commercialization Agreement (May 16th, 2014)

THIS LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the Agreement), effective as of the 26th day of March, 2007 (the Effective Date), is entered into by and between BAYER SCHERING PHARMA AG (formerly known as SCHERING AG), a German corporation, with a place of business at Muellerstrasse 178, Berlin 13342, Germany (Bayer) and SYNDAX PHARMACEUTICALS, INC., a Delaware corporation, with a place of business at 12481 High Bluff Drive, Suite 150, San Diego, California 92130 (Licensee). Bayer and Licensee are sometimes referred to herein individually as a Party and collectively as the Parties.